{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:07:47Z","timestamp":1790197667703,"version":"4.1.0"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,5,1]]},"abstract":"<jats:p>Objective. The objective of this study was to determine whether the ketogenic diet is safe, well-tolerated, and efficacious in the treatment of infantile spasms.<\/jats:p><jats:p>Methods. During a 4-year period, 23 children with infantile spasms, aged 5 months to 2 years, were started on the ketogenic diet; 9 (39%) had symptomatic infantile spasms, and 16 (70%) had hypsarrhythmia. Children had an average prediet exposure to 3.3 anticonvulsants. Two children were enrolled before any medication had been tried. Seizure reduction was analyzed retrospectively, using parent reports and electroencephalograms (EEGs) when available.<\/jats:p><jats:p>Results. At 3, 6, 9, and 12 months, 38%, 39%, 53%, and 46%, respectively, of all patients currently on the diet were &amp;gt;90% improved (3 were seizure-free at 12 months); 67%, 72%, 93%, and 100% were &amp;gt;50% improved. Fifty-six percent remained on the diet at 12 months, 46% of whom were &amp;gt;90% improved and 100% were &amp;gt;50%. Fifty percent of those with hypsarrhythmia and follow-up EEGs had EEG improvement. Fifty-seven percent had their medications reduced or discontinued by 12 months. Fifty-seven percent had improvement in development, which was correlated with seizure control. Independent factors that predicted improvement included age younger than 1 year and previous exposure to 3 or fewer anticonvulsants. No child has died, and 7 children had diet-related adverse reactions (nephrolithiasis, gastroesophageal reflux).<\/jats:p><jats:p>Discussion. The ketogenic diet is a safe, well-tolerated, and possibly effective potential alternative to other therapies for infantile spasms.<\/jats:p>","DOI":"10.1542\/peds.109.5.780","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:17:55Z","timestamp":1092442675000},"page":"780-783","source":"Crossref","is-referenced-by-count":173,"title":["Efficacy of the Ketogenic Diet for Infantile Spasms"],"prefix":"10.1542","volume":"109","author":[{"given":"Eric H.","family":"Kossoff","sequence":"first","affiliation":[{"name":"From the Departments of Neurology and Pediatrics, Pediatric Epilepsy Center, Johns Hopkins Medical Institutions, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula L.","family":"Pyzik","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics, Pediatric Epilepsy Center, Johns Hopkins Medical Institutions, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane R.","family":"McGrogan","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics, Pediatric Epilepsy Center, Johns Hopkins Medical Institutions, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen P. G.","family":"Vining","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics, Pediatric Epilepsy Center, Johns Hopkins Medical Institutions, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Freeman","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics, Pediatric Epilepsy Center, Johns Hopkins Medical Institutions, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2002,5,1]]},"reference":[{"key":"2021121006273126500_R1","unstructured":"Baram TZ. Myoclonus and myoclonic seizures. In: Swaiman KF, Ashwal S, eds. Pediatric Neurology: Principles and Practice. 3rd ed. St Louis, MO: Mosby-Year Book Inc;1999:668\u2013670"},{"key":"2021121006273126500_R2","unstructured":"Ohtahara S, Yamatogi Y. Severe encephalopathic epilepsy in infants: West syndrome. In: Pellock JM, Dodson WE, Bourgeois BFD, eds. Pediatric Epilepsy: Diagnosis and Therapy. 2nd ed. New York, NY: Demos;2001:177\u2013191"},{"key":"2021121006273126500_R3","doi-asserted-by":"crossref","unstructured":"Vigevano F, Cilio MR. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia.1997;38:1270\u20131274","DOI":"10.1111\/j.1528-1157.1997.tb00063.x"},{"key":"2021121006273126500_R4","doi-asserted-by":"crossref","unstructured":"Appleton RE, Peters ACB, Mumford JP, Shaw DE. Randomized, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia.1999;40:1627\u20131633","DOI":"10.1111\/j.1528-1157.1999.tb02049.x"},{"key":"2021121006273126500_R5","doi-asserted-by":"crossref","unstructured":"Chiron C, Dumas C, Jambaque I, et al. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res.1997;26:389\u2013395","DOI":"10.1016\/S0920-1211(96)01006-6"},{"key":"2021121006273126500_R6","doi-asserted-by":"crossref","unstructured":"Elterman RD, Shields WD, Mansfield KA, Nakagawa JA. Randomized trial of vigabatrin in patients with infantile spasms. Neurology.2001;57:1416\u20131421","DOI":"10.1212\/WNL.57.8.1416"},{"key":"2021121006273126500_R7","doi-asserted-by":"crossref","unstructured":"Johnson MA, Krauss GL, Miller NR, Medura M, Paul SR. Visual function loss from vigabatrin: effect of stopping the drug. Neurology.2000;55:40\u201345","DOI":"10.1212\/WNL.55.1.40"},{"key":"2021121006273126500_R8","doi-asserted-by":"crossref","unstructured":"Glauser TA, Clark PO, Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia.1998;39:1324\u20131328","DOI":"10.1111\/j.1528-1157.1998.tb01331.x"},{"key":"2021121006273126500_R9","doi-asserted-by":"crossref","unstructured":"Veggiotti P, Cieuta C, Rey E, Dulac O. Lamotrigine in infantile spasms. Lancet.1994;344:1375\u20131376","DOI":"10.1016\/S0140-6736(94)90741-2"},{"key":"2021121006273126500_R10","doi-asserted-by":"crossref","unstructured":"Yanai S, Hanai T, Narazaki O. Treatment of infantile spasms with zonisamide. Brain Dev.1999;21:157\u2013161","DOI":"10.1016\/S0387-7604(98)00080-1"},{"key":"2021121006273126500_R11","doi-asserted-by":"crossref","unstructured":"Kerrigan JF, Shields WD, Nelson TY, et al. Ganaxolone for treating infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res.2000;42:133\u2013139","DOI":"10.1016\/S0920-1211(00)00170-4"},{"key":"2021121006273126500_R12","doi-asserted-by":"crossref","unstructured":"Stafstrom CE, Spencer S. The ketogenic diet: a therapy in search of explanation. Neurology.2000;54:282\u2013283","DOI":"10.1212\/WNL.54.2.282"},{"key":"2021121006273126500_R13","doi-asserted-by":"crossref","unstructured":"Swink TD, Vining EPG, Freeman JM. The ketogenic diet 1997. Adv Pediatr.1997;44:297\u2013329","DOI":"10.1016\/S0065-3101(24)00055-0"},{"key":"2021121006273126500_R14","doi-asserted-by":"crossref","unstructured":"Vining EPG, Freeman JM, Ballaban-Gil K, et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol.1998;55:1433\u20131437","DOI":"10.1001\/archneur.55.11.1433"},{"key":"2021121006273126500_R15","doi-asserted-by":"crossref","unstructured":"Freeman JM, Vining EPG, Pillas DJ, et al. The efficacy of the ketogenic diet\u20141998: a prospective evaluation of intervention in 150 children. Pediatrics.1998;102:1358\u20131363","DOI":"10.1542\/peds.102.6.1358"},{"key":"2021121006273126500_R16","doi-asserted-by":"crossref","unstructured":"Nordli DR Jr, Kuroda MM, Carroll J, et al. Experience with the ketogenic diet in infants. Pediatrics.2001;108:129\u2013133","DOI":"10.1542\/peds.108.1.129"},{"key":"2021121006273126500_R17","doi-asserted-by":"crossref","unstructured":"Kinsman SL, Vining EPG, Quaskey SA. Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia.1992;33:1132\u20131136","DOI":"10.1111\/j.1528-1157.1992.tb01770.x"},{"key":"2021121006273126500_R18","doi-asserted-by":"crossref","unstructured":"Cossette P, Riviello JJ, Carmant L. ACTH versus vigabatrin therapy in infantile spasms: a retrospective study. Neurology.1999;52:1691\u20131694","DOI":"10.1212\/WNL.52.8.1691"},{"key":"2021121006273126500_R19","doi-asserted-by":"crossref","unstructured":"Baram TZ, Mitchell WG, Brunson K, Haden E. Infantile spasms: hypothesis-driven therapy and pilot human infant experiments using corticotropin-releasing hormone antagonists. Dev Neurosci.1999;21:281\u2013289","DOI":"10.1159\/000017407"},{"key":"2021121006273126500_R20","doi-asserted-by":"crossref","unstructured":"Figlewicz DP. Endocrine regulation of neurotransmitter transporters. Epilepsy Res.1999;37:203\u2013210","DOI":"10.1016\/S0920-1211(99)00072-8"},{"key":"2021121006273126500_R21","doi-asserted-by":"crossref","unstructured":"Schwartzkroin PA. Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet. Epilepsy Res.1999;37:171\u2013180","DOI":"10.1016\/S0920-1211(99)00069-8"},{"key":"2021121006273126500_R22","doi-asserted-by":"crossref","unstructured":"Koo B, Hwang PA, Logan WJ. Infantile spasms: outcome and prognostic factors of cryptogenic and symptomatic groups. Neurology.1993;43:2322\u20132327","DOI":"10.1212\/WNL.43.11.2322"},{"key":"2021121006273126500_R23","doi-asserted-by":"crossref","unstructured":"Jeavons PM, Bower BD, Dimitrakoudi M. Long-term prognosis of 150 cases of West syndrome. Epilepsia.1973;14:153\u2013164","DOI":"10.1111\/j.1528-1157.1973.tb03952.x"},{"key":"2021121006273126500_R24","doi-asserted-by":"crossref","unstructured":"Riikonen R. A long-term follow-up study of 214 children with the syndrome of infantile spasms. Neuropediatrics.1982;13:14\u201323","DOI":"10.1055\/s-2008-1059590"},{"key":"2021121006273126500_R25","doi-asserted-by":"crossref","unstructured":"Wheless JW. The ketogenic diet: an effective medical therapy with side effects. J Child Neurol.2001;16:633\u2013635","DOI":"10.1177\/088307380101600901"},{"key":"2021121006273126500_R26","doi-asserted-by":"crossref","unstructured":"Furth SL, Casey JC, Pyzik PL, et al. Risk factors for urolithiasis in patients on the ketogenic diet. Pediatr Nephrol.2000;15:125\u2013128","DOI":"10.1007\/s004670000443"},{"key":"2021121006273126500_R27","doi-asserted-by":"crossref","unstructured":"Hrachovy RA, Glaze DG, Frost JD Jr. A retrospective study of spontaneous remission and long-term outcome in patients with infantile spasms. Epilepsia.1991;32:212\u2013214","DOI":"10.1111\/j.1528-1157.1991.tb05246.x"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/5\/780\/1114534\/pe0502000780.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/5\/780\/1114534\/pe0502000780.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T05:13:20Z","timestamp":1705209200000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/109\/5\/780\/64246\/Efficacy-of-the-Ketogenic-Diet-for-Infantile"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2002,5,1]]},"published-print":{"date-parts":[[2002,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.109.5.780","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5,1]]}}}